People: Poxel SA (POXEL.PA)
Ms. Jonae R. Barnes has been Senior Vice President, Investor Relations and Public Relations of POXEL S.A. since March 14, 2016. She has 20 years of experience in the pharmaceutical and biotechnology industry. She began her career at Sepracor (now Sunovion Pharmaceuticals; acquired by Dainippon Sumitomo Pharma Co.), a specialty pharmaceutical company, where she held a series of progressively responsible management and executive roles over a 14-year period and most recently served as Senior Vice President, Investor Relations, Corporate Communications and Internal Communications. Ms. Barnes has also served in senior leadership roles at Agenus, an immuno-oncology company and Vision Medicines, an ophthalmology-focused company. In addition to her corporate appointments, she has advised privately held and publicly traded biotech companies through her investor relations consulting practice in the therapeutic areas of respiratory disorders, infectious diseases, IBS, diabetes and oncology. She holds a Bachelors degree in Political Science from Suffolk University and Masters degrees in Financial Economics and Multinational Commerce from Boston University.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|